1. Introduction {#sec0005}
===============

In late 2019, an outbreak of respiratory disease caused by a novel human coronavirus (SARS-CoV-2) was identified in Wuhan, China. The infection, now known as coronavirus disease 2019 (COVID-19), spread rapidly worldwide, and on March 11, 2020, was characterized as a pandemic by the World Health Organization ([@bib0355]). The classical routes of infection for SARS-CoV-2 are through respiratory droplets and by human-to-human contact. Within a few days of infection, a mild febrile illness appears, with dry cough and moderate to severe respiratory distress. At intensive care unit (ICU) admission, most COVID-19 patients present with hypoxemic respiratory failure ([@bib0355]), as first step of an awful systemic disease (MODS-CoV-2) (C. [@bib0250]). Chest CT scans have revealed different stages of respiratory involvement in COVID-19, making lung presentations extremely variable ([@bib0180]). Thus, different ventilatory strategies may be required for different patients, including early chest physiotherapy (CPT) and rehabilitation. CPT maneuvers are considered essential in patient management during ICU stay in general ([@bib0310]). This also applies to COVID-19 patients, as suggested in a recent paper by the Italian Association of Respiratory Physiotherapists (ARIR) ([@bib0170]). Early mobilization and rehabilitation may help prevent or mitigate sequelae related to bed rest, thus improving physical function and outcomes and reducing length of stay by increasing ventilator free-days ([@bib0160]). As this is an extremely new topic, the role of CPT in critically ill patients with SARS-CoV-2 infection requires investigation ([@bib0310]). Recent manuscripts on respiratory physiotherapy in COVID-19 patients provided general recommendations but did not focus on critically ill COVID-19 cases ([@bib0170]; [@bib0310]). The role of respiratory rehabilitation was reported in three groups of COVID-19 patients ([@bib0330]): 1) acute phase, presenting with critical respiratory impairment (emergency department, first aid, ICU, stepdown unit); 2) acute phase, with severe respiratory impairment (internal medicine, respiratory, infectious disease, or other wards); and 3) post-acute phase (other units, intermediate care facilities, subacute wards). The current review discussed the data regarding the important role of chest physiotherapy in critically ill patients with COVID-19, during mechanical ventilation and after weaning process, and how it can be safely applied with careful organization, including the training of healthcare staff and the appropriate use of personal protective equipment to minimize the risk of exposure to SARS-CoV-2.

2. Respiratory characteristics of COVID-19 and its management {#sec0010}
=============================================================

2.1. Characteristics {#sec0015}
--------------------

Respiratory characteristics of severe COVID-19 include hypoxemia and acute respiratory failure. COVID-19 is associated with peculiar characteristics in terms of respiratory mechanics, with relatively well preserved, high or low respiratory system compliance([@bib0180]). Additionally, chest CT scans of COVID-19 patients have revealed distinct patterns of pulmonary involvement: 1) a multifocal, overperfused ground-glass phenotype, with centrilobular nodules, patchy consolidation, and intra-bronchial air bronchogram; 2) dilatation and congestion of septal capillaries, followed by exudation into the alveolar space with interstitial edema; 3) vascular exudation in the interstitium, with consolidations filled by air bronchogram; 4) fibrous exudation with multiple consolidations; and 5) thickening of bronchial walls, the interlobular septum, and patchy consolidations ([@bib0180]). This explains why COVID-19 patients present with an extremely variable clinical course, and why individualized ventilatory strategies are required (C. [@bib0245]). Accordingly, distinct phenotypes based on both clinical and CT characteristics have recently been identified, as follows: 1) Phenotype-1/L-type: high or normal lung compliance associated with severe hypoxemia. This phenotype is characterized by multiple focal, overperfused ground-glass opacities. Treatment should include tidal volume of 6--8 mL/kg predicted body weight (PBW) and low to moderate positive end-expiratory pressure (PEEP) to redistribute pulmonary blood flow and shunt; 2) Phenotype-2/L-type: predominantly characterized by inhomogeneously distributed atelectasis, as well as peribronchial opacities, with hyperperfused ground glass areas. Treatment should include tidal volumes of 6 mL/kg PBW and moderate-to-high PEEP, as well as lateral or prone positioning; 3) Phenotype-3/H-type: patchy acute respiratory distress syndrome (ARDS)-like appearance, characterized by alveolar edema and low compliance. Treatment should follow standard ARDS guidelines. Steroids, prone positioning, and extracorporeal membrane oxygenation (ECMO) can be considered for the most severe cases (C. [@bib0245]; [@bib0125]).

In summary, conventional ARDS is characterized by diffuse alveolar capillary membrane damage, with edema and atelectasis in the dependent lung regions. Application of PEEP or prone position, recruits collapsed lung regions associated with improvement in respiratory mechanics and gas-exchange, while no major changes in redistribution of regional pulmonary perfusion. On the contrary in COVID-19, lesions are compartmentalized with less edema and pneumolysis, alveolar cell infiltration and necrosis. Application of PEEP or prone position result in redistribution of perfusion, but not alveolar recruitment. In this sense, COVID-19 pneumonia represents a "true" primary ARDS, as defined previously ([@bib0255]).

2.2. Ventilatory management {#sec0020}
---------------------------

At the beginning of the pandemic, management of COVID-19 was based on classification of the respiratory involvement as ARDS-like (C. [@bib0245]), thus consisting of low tidal volume (V~T~; 6 mL/kg PBW) and plateau pressure (\<30 cmH~2~O), with high PEEP ([@bib0115]). Initial guidelines for the management of COVID-19 patients ([@bib0005]) corroborated this strategy, recommending low-V~T~ ventilation (4−8 mL/kg PBW) with PEEP levels titrated according to peripheral oxygen saturation (SpO~2~). However, this should only be applied to patients with ARDS-like COVID-19 (C. [@bib0245]; [@bib0125]). Continuous positive-pressure ventilation (CPAP) or non-invasive ventilation (NIV) with vigorous breathing effort may be detrimental in COVID-19, as it could increase the risk of patient self-inflicted lung injury (P-SILI) ([@bib0300]). In fact, as suggested by Gattinoni et al. ([@bib0125]), longer periods with non-invasive ventilatory supports should be avoided and intubation prioritized in order to prevent the development of P-SILI, which may worsen lung damage. Additionally, in non-intubated patients, an esophageal balloon should be inserted to maintain the pressure below 15 cmH~2~O, thus limiting the risk of P-SILI. On the other hand, caution should be adopted with early intubation since endotracheal intubation and mechanical ventilation may also lead to lung damage. Therefore, whether to choose early intubation or not should be carefully weighed ([@bib0315]). The cardiac abnormalities reported in COVID-19 might be distinguished based on patient's phenotype. In the phenotype-1/L-type, the right heart impairment is estimated to be less evident than in the phenotype-3/ H-type due to the expected lower ventilatory pressures and tidal volumes delivered to the lungs ([@bib0140]). Following increased respiratory effort, phenotype-1/ [l]{.smallcaps}-type may reduce stroke volume as a result of ventricular interdependence with consequent diastolic ventricular septal shift. Additionally, high pressures and tidal volumes applied on a poorly recruitable lung, such as observed in this phenotype, may yield haemodynamic instability and fluid retention ([@bib0125]). On the other hand, when positive-pressure ventilation is applied on a phenotype-3/H-type, ventricular dilatation, tricuspid insufficiency, reduced right-heart systolic function, and left-heart compression may occur, determining the so called "ventilator-induced heart dysfunction" ([@bib0140]).

The need for recruitment maneuvers (RMs) should be individualized on the basis of each patient's phenotype, since several cases of impaired shunt fraction or poor lung recruitability have been identified (C. [@bib0245]). Traditional RMs are preferred instead of an incremental PEEP strategy ([@bib0005]). Prone positioning, which redistributes pulmonary blood flow and alveolar ventilation to improve gas exchange, may be considered in the management of mechanically ventilated critically ill COVID-19 patients ([@bib0145]). Evidence of the efficacy of prone positioning in COVID-19 is still lacking, although clinical knowledge suggests reserving this strategy only for those subtypes of patients which should benefit based on chest CT findings ([@bib0180]) (C. [@bib0245]). However, performing a CT-scan in each patient became unfeasible due to the high turnout of patients (up to 60--80 affected patients every day) during the peak of pandemic, limiting the specific phenotype diagnosis and subsequent therapeutic choices. Therefore, clinical analysis, chest-X-ray and lung ultrasound (LUS) are regarded as better options to assess COVID-19 phenotypes at bedside ([@bib0085]). The sensitivity and specificity of LUS in COVID-19 patients remain to be determined. Four basic patterns at LUS have been identified: 1) normal pattern: A-lines and \<3 B-lines; 2) mild disease: ≥3 B-lines with some confluents and thickened pleura (phenotype 1--2 and [l]{.smallcaps}-type); 3) B-lines with broken pleural line; 4) typical ARDS pattern with subpleural consolidation (phenotype 3 and H-type). LUS cannot be considered as a substitute of CT-scan but can be a valid option when CT-scan is difficult to be done ([@bib0095]).

Prone positioning has also been used in small cohorts of awake COVID-19 patients during spontaneous or assisted breathing. Among 24 patients in one study, 15 tolerated the prone position for more than 1 h, of whom only six showed increased oxygen saturation, and half of them returned to baseline levels after supine positioning ([@bib0105]). Larger randomized controlled trials are underway to elucidate whether prone positioning during spontaneous and assisted breathing can be used to reduce the intubation rate ([@bib0025]; [@bib0010]). If beneficial, it may be further considered as a novel respiratory physiotherapy strategy for awake patients with COVID-19 and ARDS. Finally, a substantial number of COVID-19 patients are able to start the weaning process. Traditional criteria for extubation are considered suitable for COVID-19 patients. Patients who might be eligible for a spontaneous breathing trial should receive CPT before and after extubation, since improved outcomes have been observed in patients who underwent respiratory physiotherapy around extubation time ([@bib0170]; [@bib0310]). NIV, CPAP, and high-flow nasal oxygen (HFNO) should also be considered for short periods after extubation, until complete respiratory autonomy is reached ([@bib0170]).

3. Chest physiotherapy for mechanically ventilated COVID-19 patients {#sec0025}
====================================================================

Physiotherapy has proven effective for improving long-term physical function among ICU survivors ([@bib0060]). However, the true benefit of chest physiotherapy in ICU remains controversial, especially in those patients with already established alveolar damage ([@bib0170]; [@bib0310]). The ARIR recently published a position paper concerning the role of chest physiotherapy in COVID-19 patients ([@bib0170]), suggesting limitation of some procedures---such as diaphragmatic breathing, bronchial hygiene, lung re-expansion techniques, manual mobilization, respiratory muscle training, nasal washing, and exercise training---in the acute phase of the illness. The literature suggests that physiotherapy maneuvers result in significant changes in respiratory function ([@bib0080]), as well as in changes of cardiovascular and cerebral hemodynamic ([@bib0080]), which could lead to potentially harmful effects.

Physiotherapy for critically ill patients in general, in critical and post-critical illness, is based on a multisystem approach which comprises not only chest physiotherapy but also musculoskeletal rehabilitation, in order to reduce the incidence of complications, encourage weaning from mechanical ventilation, and facilitate recovery of functional autonomy ([@bib0310]). Few literature is available on physiotherapy during COVID-19 pandemic, especially regarding chest physiotherapy in ICU patients ([@bib0170]) ([@bib0285])

Conventional chest physiotherapy maneuvers for critically ill patients in general include airway clearance techniques, lung re-expansion through RMs, patient-ventilator interactions, inhalational therapies, humidification, and tracheostomy and bronchial aspiration ([@bib0360]). Other equally efficient methods, which can replace these techniques, have been recently identified and introduced in clinical practice. Since the severe pulmonary illness associated with COVID-19 can lead to long-term mechanical ventilation with a high ICU mortality rate, we believe that early physiotherapy and mobilization may be essential for improving outcomes. In the following paragraphs, we describe the chest physiotherapy maneuvers applied in COVID-19 patients in our ICU and their rationale. [Fig. 1](#fig0005){ref-type="fig"} summarizes the physiotherapy techniques currently applied in our ICU in COVID-19 patients.Fig. 1Genoa−COVID-19 algorithm for respiratory physiotherapy.Chest physiotherapy techniques commonly used in our COVID-19 unit during mechanical ventilation, before and after extubation. CIP, critical illness polyneuropathy; ZEEP, zero PEEP; PEEP, positive end-expiratory pressure; HEPA, exhalation/expiratory filter; EPAP, expiratory positive airway pressure; CPAP, continuous positive airway pressure; HFNO, high flow nasal oxygen; NIV, non-invasive ventilation.Fig. 1

3.1. Chest physiotherapy during mechanical ventilation {#sec0030}
------------------------------------------------------

Early physiotherapy, i.e., started during mechanical ventilation, is considered feasible and safe to improve patient performance and long-term quality of life ([@bib0160]), although this has not yet been proven in COVID-19. Among chest physiotherapy strategies during mechanical ventilation, mucus clearance and alveolar RMs are very commonly applied in clinical practice. Sputum production was reported in about 34 % of COVID-19 patients ([@bib0135]), thus suggesting that, by promoting mucus clearance during mechanical ventilation, early physiotherapy interventions (such as subglottic secretion drainage, postural hygiene, and ventilator hyperinflation) may produce beneficial effects in this new critically ill population ([@bib0310]). Before starting chest physiotherapy, we recommend the use of adequate personal protective equipment, limiting healthcare workers in the room to one physician and one physiotherapist, as well as choosing a negative-pressure chamber if available ([@bib0170]; [@bib0310]).

### 3.1.1. Alveolar recruitment {#sec0035}

RMs are transient increases in transpulmonary pressure that may open non-aerated or poorly aerated areas of the lung, while concomitantly increasing the risk of endothelial-cell damage and increased capillary permeability ([@bib0280]). Although alveolar recruitment can be obtained through a variety of techniques during mechanical ventilation in critically ill patients in general, whether alveolar RMs should be used at all has been widely debated. In experimental ARDS, "slow" RMs showed a more homogeneous inflation of the lung and led to functional impairment with less ventilator-induced lung injury (VILI) as compared to "fast" RMs ([@bib0275]). In a large, multicenter, randomized controlled trial of ARDS patients, a strategy based on lung RMs and PEEP titration according to the best respiratory system compliance resulted in increased 28-day all-cause mortality than a low-PEEP strategy ([@bib0075]), thus suggesting this type of recruitment is best avoided. Different respiratory phenotypes of COVID-19 have been identified (C. [@bib0245]; [@bib0125]). As suggested above, not all phenotypes can benefit from RMs (C. [@bib0245]). We suggest the use of LUS as well as monitoring of the partial pressure of oxygen during RMs to identify COVID-19 patients who are responsive to alveolar recruitment, as suggested in the literature in critically ill patients in general ([@bib0320]). [Fig. 2](#fig0010){ref-type="fig"} shows the use of lung ultrasound to evaluate RM in a COVID-19 patient.Fig. 2Stepwise recruitment manoeuvres and lung ultrasound.Results of chest physiotherapy evaluated by lung ultrasound. The figure represents a stepwise recruitment manoeuvres (RM) at different positive end-expiratory pressure (PEEP) levels that allowed to recruit atelectatic areas of a COVID-19 patient.Fig. 2

### 3.1.2. Drainage of subglottic secretions {#sec0040}

In intubated and mechanically ventilated critically ill patients in general, the tracheal tube completely bypasses the larynx, facilitating passage of microbes to the lower respiratory tract, which can lead to nosocomial infections such as ventilator-associated pneumonia (VAP) and tracheobronchitis ([@bib0195]). To date, one of the most fearsome complications of SARS-CoV-2 infection is secondary bacterial infection. In a retrospective single-center study, bacterial infections were found in 43 % of elderly patients infected with SARS-CoV-2, and were a strong predictor of overall risk of death ([@bib0350]). Similar findings were reported in a case series of COVID-19 patients ([@bib0100]). Subglottic secretion drainage (SSD) has been proposed in critically ill patients in general to reduce the risk of VAP ([@bib0165]). According to a recent meta-analysis of 20 randomized controlled trials ([@bib0210]), SSD reduced VAP incidence and shortened the duration of mechanical ventilation in four clinical trials, whereas no differences were found for ICU length of stay or for in-hospital and ICU mortality. Moreover, the use of endotracheal tubes with an incorporated polyurethane cuff and SSD maneuvers helped reduce the risk of early- and late-onset VAP as compared to traditional care ([@bib0205]). The safety of SSD also remains controversial. Although SSD reduced VAP incidence, a recent meta-analysis of 17 randomized controlled trials found no benefits in terms of duration of mechanical ventilation, ICU length of stay, ventilator-associated events, or antibiotic use ([@bib0065]), raising further controversy as to the use of this technique. Although the literature is not conclusive concerning the real clinical benefits of SSD in COVID-19, we believe that a strategy based on early physiotherapy (including SSD) may reduce the risk of secondary pulmonary infections. Nevertheless, the only available paper on CPT in COVID-19 does not suggest that this technique should be started too early, and explains that SSD should be performed only under a closed aspiration circuit in order to limit droplet dispersion and avoid PEEP loss ([@bib0170]). Based on our direct experience with respiratory physiotherapy in our ICU, we propose a novel method to assess this maneuver and reduce the risk of aerosol dispersion. In brief, we perform SSD by reducing the endotracheal cuff pressure, thus providing subglottic aspiration with a closed-aspiration circuit, while simultaneously aspirating the oral cavity with another circuit. In our experience, this technique limits airborne dispersion and ensures complete SSD. This technique is depicted in [Fig. 3](#fig0015){ref-type="fig"} .Fig. 3Genoa−COVID-19 subglottic secretion drainage novel technique.Genoa−COVID-19 subglottic secretion drainage technique using a mixture of closed aspiration circuit and open aspiration circuit to minimize airborne dispersion.Fig. 3

### 3.1.3. Postural drainage {#sec0045}

While postural drainage has been abandoned because it requires a considerable time investment and provides only minor clinical benefit, patient positioning is still considered an optimal and quick technique to mobilize secretions and increase lung volumes, perfusion, and oxygenation ([@bib0185]). Critically ill patients are at high risk of nosocomial infections, and the aspiration of mucus from the endotracheal tube cuff to the lower respiratory tract is the main mechanism for the development of ventilator-associated infections ([@bib0185]). Patient positioning has been identified as a major contribution to nosocomial infections. In a large, multicenter randomized controlled trial in critically ill patients in general, the incidence of VAP was 0.5 % in the lateral Trendelenburg position and 4% in the semi-recumbent position (head of bed elevated to 30−45° above horizontal plane), whereas no differences were found in terms of 28-day mortality and other secondary outcomes ([@bib0190]). Although no differences in outcome were found between the two groups in this study, the semi-recumbent position may increase the hydrostatic pressure exerted by bacteria around the endotracheal cuff, thus facilitating gravitational pulmonary aspiration ([@bib0185]). Another study which compared the semi-recumbent position and supine positions did not find any differences in outcome ([@bib0325]). Finally, a recent meta-analysis of 10 randomized controlled trials compared the semi-recumbent and supine positions, concluding that a higher head position (30−60°) reduces the risk of VAP ([@bib0340]). As in ARDS, some COVID-19 patients require prone positioning to homogenize lung perfusion and improve ventilation/perfusion mismatch ([@bib0125]). Prone positioning may reduce the risk of VAP by a still-unclear mechanism, which may involve prevention of lung translocation of oropharyngeal pathogens and easier drainage of respiratory secretions ([@bib0185]). In a meta-analysis of 1066 ARDS patients, prone positioning resulted in lower VAP incidence. Conversely, the most recent study which assessed the use of prone position in ARDS patients found a higher VAP rate in the prone group than in the supine group, and VAP occurrence in the prone position group was associated with higher mortality ([@bib0030]). The ARIR position paper on CPT in COVID-19 suggests early implementation of postural changes, although no conclusive data are available for COVID-19. In summary, the above-mentioned positioning maneuvers may represent an important strategy to reduce the risk of secondary respiratory bacterial infections in mechanically ventilated COVID-19 patients, facilitating mucus clearance and mobilizing secretions, thereby improving lung volumes, perfusion, and oxygenation.

### 3.1.4. Ventilator hyperinflation {#sec0050}

Ventilator hyperinflation is a technique commonly applied by physiotherapists to promote airway clearance in mechanically ventilated ICU patients ([@bib0305]). Ventilator hyperinflation requires the use of a ventilator generating an expiratory flow rate bias when the peak inspiratory flow rate is less than 90 % of the peak expiratory flow rate, with a minimal difference of 17 L/min and an expiratory flow rate of 40 L/min ([@bib0335]). Recently, Ribeiro et al. compared six models of ventilator hyperinflation. Volume-controlled ventilation and pressure support ventilation achieved the best effectiveness score (p \< 0.05), with less patient-ventilator asynchronies in pressure support mode ([@bib0235]). However, it is still uncertain whether ventilator asynchronies are associated with a worse outcome ([@bib0050]). The effectiveness of manual versus ventilator hyperinflation has been compared both in clinical and pre-clinical settings. In an experimental study in pigs, neither manual nor ventilator hyperinflation modified pulmonary parameters. Rather, both maneuvers significantly decreased inspiratory flow and increased peak expiratory flow up to 44 L/min ([@bib0200]). In summary, the ventilator hyperinflation technique may be considered for severe COVID-19 patients to promote airway clearance, although its actual beneficial effects have yet to be proven.

### 3.1.5. Neuromuscular rehabilitation {#sec0055}

ICU-acquired weakness is a very common global muscle weakness that affects around 50 % of ICU patients mechanically ventilated for more than 48 h ([@bib0150]). The risk factors include bed rest, sepsis and multiorgan failure, hyperglycemia, and use of corticosteroids and neuromuscular blockers ([@bib0270]). The literature published to date about critically ill COVID-19 patients has confirmed a need for long-term mechanical ventilation, high doses of neuromuscular blocking agents, and prolonged bed rest (C. [@bib0245]; [@bib0125]). Moreover, one of the key therapeutic strategies for these patients has been the early use of corticosteroids ([@bib0035]), which is another important risk factor implicated in ICU-acquired weakness ([@bib0270]). The ARIR position paper ([@bib0170]) suggests careful planning of protocols for early mobilization in COVID-19 patients, rather than random application of these techniques. Inspiratory muscle training, electrical muscle stimulation, and early mobilization could be considered as key strategies in the prevention of ICU-acquired weakness ([@bib0270]; [@bib0220]), and should be used rationally to help ensure rapid recovery of those who can benefit. A systematic review and meta-analysis concluded that inspiratory muscle training is able to improve maximal inspiratory pressure and weaning success ([@bib0110]). However, improved muscle function and strength have not translated into improved ICU outcomes. One randomized controlled trial reported improved quality of life within 2 weeks of interventions, but further studies are needed to confirm these findings ([@bib0040]). While evidence for these strategies is still limited, early mobilization of critically ill patients is feasible, safe, and proven to reduce ICU length of stay ([@bib0295]), as recently confirmed by the rehabilitation strategies applied in COVID-19 patients at San Raffaele Hospital, Milan, Italy. These were based on a multidisciplinary strategy ([@bib0155]). Therefore, it should be considered and implemented early in the course of ICU stay in patients with severe COVID-19 ([@bib0170]).

3.2. Pre-extubation chest physiotherapy {#sec0060}
---------------------------------------

As for intubation, the extubation process in critically ill COVID-19 patients should be carefully organized, considering the high risk of aerosol generation ([@bib0310]). Health care workers should begin the process only after donning appropriate personal protective equipment and, if possible, should organize the procedure in a negative-pressure room with an antechamber to minimize exposure ([@bib0310]). Before extubation, an air leak test is recommended. Endotracheal suctioning should also be performed, although during cuff deflation and extubation it produces leakage. The application of a CPAP of 15 cmH~2~O or pressure support ventilation (PSV) at 15/10 or 20/5 cmH~2~O can also result in lower leakage during the extubation phase ([@bib0015]). A recent study in critically ill patients demonstrated that using positive-pressure ventilation before extubation reduced the incidence of major complications ([@bib0020]). Alveolar RMs, when feasible and necessary, may be considered before extubation to reduce alveolar derecruitment ([@bib0280]).

Criteria for extubation of COVID-19 patients are the same as for other critically ill patients. A daily awakening trial followed by a spontaneous breathing trial (SBT) is suggested to improve outcomes in critically ill mechanically ventilated patients ([@bib0130]). In 2017, Sklar et al. conduced a meta-analysis of 16 randomized controlled trials to evaluate which SBT test determines higher breath effort. Pressure support ventilation resulted in lower breath effort when compared to use of a T-piece, while a continuous positive airway pressure of 0 cmH~2~O and T-piece more accurately reflected the post-extubation physiologic condition ([@bib0290]).

It should be noted that SBTs can be exhausting, thus reconnecting patients to the ventilator for 1 h after the SBT before extubation is recommended ([@bib0120]). Finally, a recent paper proposed a novel technique to limit aerosol generation during extubation of COVID-19 patients. The authors suggested the so-called "mask over tube" method, which uses a second airway filter to avoid staff exposure ([@bib0090]).

In [Fig. 4](#fig0020){ref-type="fig"} we propose a comprehensive algorithm of physiotherapy maneuvers for extubation of COVID-19 patients ([@bib0290]):•Use adequate personal protective equipment, limit healthcare workers in the room to one physician and one physiotherapist, choose a negative-pressure chamber if available ([@bib0170]; [@bib0310]);•Bed head elevation and prolonged sitting, recruitment maneuvers ([@bib0170]; [@bib0310]);•Air leak test ([@bib0265]);•SBT with 0 cmH~2~O pressure support, PEEP = 6 cmH~2~O, FiO~2~ = 0.35 for 30 min; if the patient passes the SBT (P/F \> 200, V~T~ = 6 mL/kg PBW, SpO~2~ target, RR \< 22 breaths/min) ([@bib0055]), set a final cycle of pressure support ventilation with 8 cmH~2~O of pressure support and PEEP = 6 cmH~2~O for at least 1 h to rest muscles ([@bib0120]);•Suction subglottic secretions using a closed-aspiration circuit ([@bib0170]; [@bib0310]);•Choose the next ventilatory support modality (NIV, CPAP, HFNO);•Set PEEP and pressure support \< 30 cmH~2~O (to recruit and prevent VILI) immediately before extubation ([@bib0125]);•Extubate while aspirating secretions via a closed circuit ([@bib0170]; [@bib0310]);•Be prepared for a rapid, skilled re-intubation if necessary. Fig. 4Genoa−COVID-19 algorithm for extubation and weaning.Algorithm for weaning and extubation of COVID-19 patients routinely used in our intensive care unit. PS, pressure support; PEEP, positive end-expiratory pressure; FiO~2~, fraction of inspired oxygen; SpO~2~, peripheral saturation of oxygen; P/F, partial pressure of oxygen/FiO~2~ ratio; RR, respiratory rate; Vt, tidal volume; SBT, spontaneous breathing trial; PSV, pressure support ventilation; PaCO~2~, partial pressure of carbon dioxide; PBW, predicted body weight; NIV, non-invasive ventilation; CPAP, continuous positive airway pressure.Fig. 4

3.3. Post-extubation chest physiotherapy {#sec0065}
----------------------------------------

Recent studies have confirmed that CPT in critically ill patients is able to improve respiratory function immediately after extubation ([@bib0225]; [@bib0345]). As suggested by the ARIR position paper ([@bib0170]), CPT may be considered in all COVID-19 patients who require mechanical ventilation, as well as during and after the extubation process. The most common techniques applied after extubation include neuromuscular electrical stimulation, early sitting, airway suctioning, swallow screening, manual hyperinflation, airway cleaning techniques, early mobilization, positive expiratory pressure with an EzPAP device, positive expiratory pressure, active cycle of breathing techniques (ACBT), intermittent positive pressure breathing, forced expiratory technique, assisted or stimulated cough maneuvers, insufflation-exsufflation, CPAP, NIV, and HFNO ([@bib0170]). Moreover, we recommend a water swallow test (WST) ([@bib0045]) to evaluate patients at risk for dysphagia-associated aspiration.

The following section provides a brief overview of techniques that could be applied to critically ill COVID-19 patients in the post-extubation phase. These techniques pose a high risk of aerosol generation, which hinders their use ([@bib0310]). Nevertheless, based on our direct experience with COVID-19 patients, we believe that with proper personal protective equipment and airborne precautions, all of these techniques can be safely applied---including those not recommended or even recommended against elsewhere in the literature ([@bib0170]; [@bib0310]).

### 3.3.1. Active cycle of breathing techniques {#sec0070}

ACBTs promote airway clearance, thus avoiding sputum retention and inflammation. ACBTs include the forced expiration technique (FET) and chest expansion exercises ([@bib0175]). The FET consists of one or two forced expirations followed by relaxed breathing. In a meta-analysis of 24 randomized controlled trials, ACBTs were associated with higher sputum clearance, vital capacity, and forced expiratory volume in respect to conventional physiotherapy ([@bib0175]). A meta-analysis of 14 studies concluded that participants prefer autogenic drainage over ACBTs, which in turn are preferred over airway oscillating devices. No differences were found in term of lung function, disease exacerbations, sputum weight, oxygen saturation, or exercise tolerance, casting doubt as to the real efficacy of ACBTs ([@bib0215]). No data are available specifically for COVID-19 patients. These maneuvers should only be performed while wearing personal protective equipment in a negative-pressure room ([@bib0310]).

### 3.3.2. Manual hyperinflation {#sec0075}

Manual hyperinflation is a technique that delivers a high tidal volume up to a Peak pressure of 40 cmH~2~O. It starts with a slow inspiration, followed by a 2- or 3-second inspiratory hold, followed by a rapid expiration (similar to forced expiration). Some techniques include the use of a manual hyperinflation bag with a PEEP valve, which allows maintenance of PEEP and thus reduces derecruitment and atelectrauma. The advantage of using manual hyperinflation over ventilator hyperinflation is the proprioceptive feedback from the bag to the operator, while the advantage of ventilator hyperinflation is the safe maintenance of PEEP and standardization and reproducibility of the technique. In awake patients, use of the manual hyperinflation technique is considered simpler than a ventilator hyperinflation manoeuvre ([@bib0230]). This technique has not yet been studied in COVID-19. As for the other techniques mentioned, personnel protective equipment must be worn, and the procedure performed in a negative-pressure room if available.

### 3.3.3. EzPAP {#sec0080}

The EzPAP is a positive expiratory pressure device that delivers a continuous expiratory pressure through the mouth using airflow delivered from a flowmeter to treat and prevent atelectasis. In a randomized controlled trial of 210 postoperative patients randomly allocated to EzPAP or control, SpO~2~ did not differ between the two groups, whereas the EzPAP group restarted oxygen therapy less frequently and had a reduced incidence of postoperative complications. In patients at risk of hypoxemia, the EzPAP improved pulmonary oxygenation ([@bib0240]). Another trial compared incentive spirometry to EzPAP in 112 postoperative patients, and found no differences between the two strategies in terms of lung expansion or postoperative pulmonary complications ([@bib0260]). As for other techniques, data are limited in COVID-19. Although the risk for health care workers is higher with such devices, they have proven beneficial in critically ill patients. Thus, using personal protective equipment, disposable circuits, airborne precautions, and placing a filter over the machine and patient is strongly recommended ([@bib0310]).

### 3.3.4. Mechanical insufflation/exsufflation {#sec0085}

Mechanical insufflation/exsufflation is a device that promotes maximal lung inflation, followed by a negative pressure, in order to simulate cough. This technique is used when the patient is unable to cough or coughs ineffectively. It is particularly efficient when provided in conjunction with assisted cough techniques or thoraco-abdominal trust ([@bib0230]). No evidence in COVID-19 is available; however, the same recommendations described above may be applied. In our unit, we use a face mask and oral aspiration during the procedure to reduce aerosol dispersal.

### 3.3.5. Sputum induction {#sec0090}

Although sputum induction has not been recommended because of the high risk of aerosol generation ([@bib0310]), critically ill patients (included those with COVID-19) frequently develop neuromuscular weakness and swallowing dysfunction, thus often requiring sputum induction. Based on our experience and on clinical evidence, we believe that sputum should be incentivized in COVID-19 patients to reduce the rate of reintubation, but only in case personal protective equipment are guaranteed.

### 3.3.6. Neuromuscular mobilization {#sec0095}

As proposed above, early neuromuscular mobilization should be considered to facilitate recovery, particularly in the post-extubation phase, as around 50 % of mechanically ventilated patients develop ICU-acquired weakness ([@bib0150]).

### 3.3.7. NIV, CPAP, HFNO {#sec0100}

Post-extubation respiratory support may be required to reduce the risk of reintubation. In the specific setting of COVID-19, the risk of extubation also includes health personnel. As suggested by the ARIR position statement ([@bib0170]), conventional oxygen therapy (such as a nasal cannula) should be avoided in order to reduce droplet dispersion. A face mask with an oxygen flow up to 5 L/min, a reservoir mask up to 10 L/min, or a Venturi mask with 0.6 FiO~2~ may be preferred, and a surgical mask should be placed over the oxygen mask to further reduce dispersion. For patients who require HFNO, flows up to 50 L/min and FiO~2~ up to 0.6 should be adopted, again covering the patient's mouth and nose with a surgical mask ([@bib0310]). The ARIR suggests that, for patients not admitted to the ICU, CPAP and NIV can be employed for no longer than 1 h, followed by reintubation if no improvement is observed ([@bib0170]). In our ICU experience, 2- to 3 -h cycles of NIV can be beneficial for COVID-19 patients. Among the available interfaces, the helmet is considered the safer choice to minimize risk to health care workers, as it inherently limits droplet dispersion ([@bib0170]); a viral filter should be placed on the expiratory valve to limit aerosol dispersion. A protocol for a randomized controlled trial comparing early post-extubation respiratory support versus standard care was recently proposed, and the trial is ongoing ([@bib0070]). Finally, when considering post-extubation respiratory support strategies, it is worth noting that the peripheral oxygenation target for COVID-19 patients who present with hypoxemic respiratory failure is an SpO~2~ of 96 % ([@bib0310]).

4. Conclusions {#sec0105}
==============

COVID-19 is a new disease process that has not been completely characterized. Although there is still no evidence of the efficacy of chest physiotherapy in the specific setting of COVID-19, several established physiotherapy techniques can be safely applied in this subgroup of patients to reduce atelectasis and improve outcomes. All physiotherapy interventions should be carefully organized, and personnel must always wear appropriate personal protective equipment to minimize exposure. Further studies are warranted to confirm the efficacy of CPT techniques in this new critically ill population.
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